#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Langerhans cell sarcoma Short stature homeobox gene mutation Cholangitis sclerosing Endocrine ophthalmopathy Hereditary angioedema with C1 esterase inhibitor deficiency Osteosarcoma metastatic Primary myelofibrosis Growth hormone deficiency Familial hypertriglyceridaemia Raynaud's phenomenon Von Willebrand's disease Acute on chronic liver failure Partial lipodystrophy Antiphospholipid syndrome Duchenne muscular dystrophy gene carrier More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma – Basic Information Mastocytosis – Diagnostics Erdheim-Chester disease Lysosomal storage disorder – Trials in Disease Burkitt’s lymphoma – Life with Disease Nodal marginal zone B-cell lymphoma – Basic Information Haemophilia A without inhibitors – Basic Information Uterine leiomyosarcoma – Basic Information Alternating hemiplegia of childhood – Trials in Disease Noonan syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Hmb-001 Montelukast Dapagliflozin Propanediol Ripasudil Lerodalcibep Cemiplimab GSK4418959A Artemisia Vulgaris (312) Lutropin Alfa Nomegestrol Acetate Sodium Lactate Bi 1819479 Goserelin Acetate ATIRMOCICLIB Salbutamol Sulfate Linsitinib Hydrocortisone Acetate Meropenem Anhydrous Relatlimab Citalopram More therapies…

    Learn about Your Condition

    Alopecia areata Cushing's syndrome Antisynthetase syndrome Osteosarcoma metastatic Brain cancer metastatic Incontinence Hereditary ataxia Labour pain Iron deficiency anaemia Diffuse large B-cell lymphoma Genital herpes simplex Fibrous dysplasia of bone Muscle hypertrophy Addison's disease Hypertonic bladder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Type 2 diabetes mellitus

  • Study on the Effects of Ertugliflozin and Semaglutide on Heart Health in Patients with Type 2 Diabetes

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Canagliflozin
    • Ertugliflozin
    • Insulin Aspart
    Italy

  • Study on the Effect of Semaglutide on Healing Foot Ulcers in Patients with Type 2 Diabetes

    Recruiting

    2 1 1
    Investigated Diseases:
    • Diabetic foot
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Semaglutide
    Denmark

  • Study on Fecal Microbiota Transfer for Better Diabetes Control in Adults with Type 2 Diabetes After Bariatric Surgery

    Recruiting

    3 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Allogeneic Faecal Microbiota, Pooled
    • Placebo
    France

  • Study on Using Dapagliflozin, Semaglutide, and Finerenone to Prevent Heart and Kidney Complications in Patients with Type 2 Diabetes

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Finerenone
    • Dapagliflozin
    • Semaglutide
    Denmark Spain

  • Study on Dapansutrile for Patients with Type 2 Diabetes Not Well Controlled on Standard Treatment

    Recruiting

    2 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Dapansutrile
    Belgium France Germany

  • Comparison of dapagliflozin versus metformin treatment in patients with early stage type 2 diabetes to evaluate survival and complications

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Dapagliflozin Propanediol
    Sweden
Previous Page
1 2 3 4 … 13
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!